Overall Winner - Life Sciences - Alexion Pharmaceuticals Inc. - 2010 Marcum Tech Top 40

Loading...

Sign in or sign up now!
Alert icon
Upgrade to the latest Flash Player for improved playback performance. Upgrade now or more info.
99 views
Loading...
Alert icon
Sign in or sign up now!
Alert icon

Uploaded by on Jun 29, 2011

The winner of this year's Marcum Tech Top 40 is Cheshire, CT-based Alexion Pharmaceuticals Inc. in the Life Sciences category. The company has achieved revenue growth of 24,726 percent over the past four years and a significant market presence with Soliris®, a product approved for the treatment of patients with paroxysmal nocturnal hemogolbinuria (PNH), a rare, but progressive and life-threatening disease characterized by the excessive destruction of red blood cells.

  • likes, 1 dislikes

Link to this comment:

Share to:
see all

All Comments (2)

Sign In or Sign Up now to post a comment!
  • Achieved revenue growth of 24,726 percent over the past four years.. That's because you are RAPING people with this rare disease. You represent all that is wrong in this world. Why don't you work on a CURE rather than a lifelong treatment to keep making money off of us? Ohhhhhh right... because if you did have a cure, you wouldn't make any more money! I get it! The fact that you can stand up there an accept an award for such a thing... makes me sick.

  • Wow... I didn't know they gave an award for making money off of the horrible rare illness that I am suffering from. I'd rather die than watch my parents give their hard earned money to you greedy selfish pigs. Do you sleep better at night knowing you charge 500,000/year for the ONLY life saving medication available to those of us with PNH? When there are only 4,000- 8,000 of us? Alexion Pharmaceuticals, Fuck You.

Loading...

Alert icon
0 / 00Unsaved Playlist Return to active list
    1. Your queue is empty. Add videos to your queue using this button:
      or sign in to load a different list.
    Loading...Loading...Saving...
    • Clear all videos from this list
    • Learn more